U.S. Software Stock News

Cheniere Energy Partners just delivered one of those quarters that makes the share price move look out of step with the story. The stock is down about 1.8% since the earnings release, yet Q2 landed with US$2.40 in basic earnings per unit on US$2.58b of revenue and a trailing P/E sitting around 10.8x. For an LNG export partnership often viewed as a mature, yield focused vehicle with balance sheet questions, the headline this quarter is simple: profitability remains solid while the valuation...

TETRA Technologies, Inc. reported past second-quarter 2026 results, with sales rising to US$185.66 million from US$173.87 million a year earlier, while net income eased to US$10.24 million and diluted EPS from continuing operations slipped to US$0.07 from US$0.08. The combination of higher revenue but lower profitability highlights cost and margin pressures that matter for how investors assess TETRA’s evolving earnings profile. We’ll now examine how this mix of rising sales but softer...

Applied Optoelectronics stock jumped 9% to US$135.44 into the earnings close, which suggests investors were leaning bullish before they even read the fine print. The headline is simple. The company reported record Q2 revenue of US$191.9m and moved to non GAAP profitability with US$5.5m in net income. For a stock that has swung sharply over the past three months, that combination of rapid top line growth and a clean non GAAP profit is the kind of result that can significantly influence...

Roivant Sciences stock has been grinding higher for months, then tacked on another 3.5% after the latest earnings, even as the headline numbers flipped from a quarterly profit to a fresh loss. The market is cheering a biopharma story that is still all about the balance sheet. Cash sits just under US$4.0b and reported operating spending in research and development and general and administrative runs at roughly US$300m for the quarter. The sentiment test now is simple: Are investors paying up...

HA Sustainable Infrastructure Capital shares jumped 6.3% to US$40.66 in the first full session after earnings, and the move speaks directly to one thing: the market is repricing the earnings power rather than the asset base. Adjusted earnings of US$200 million for the first half and adjusted return on equity above 15% put profit quality at the center of this reaction. The key question for you is whether that one-day surge fully reflects the upgraded 2028 earnings outlook or if sentiment is...

Kodiak Gas Services came into this print with a rich 75.4x trailing P/E and a stock that had slipped roughly 14% over the past month. After Q2 earnings, the share price jumped 5.4% to US$59.94. The market finally leaned into the story instead of the skepticism. The hook is simple. This was a quarter about operating power in an asset heavy energy services business. Revenue reached US$391.1m and adjusted EBITDA hit a record US$217m, backed by a 98.2% utilized compression fleet and solid early...

PAR Technology stock was up about 4% to roughly US$17.80 by the close after its Q2 report, a firm move for a company that is still loss making. The headline was clear for a restaurant and retail software platform that investors often value on growth and cash burn. Revenue reached about US$133 million and adjusted earnings before interest, tax, depreciation and amortization turned positive at roughly US$14 million. Short term traders saw enough in those cash flow and profitability strides to...

Maravai LifeSciences stock barely flinched after earnings, slipping just 0.3% to US$6.23, yet the numbers told a far more emotional story for a loss making life sciences supplier trying to rebuild trust. The headline this quarter was a sharp squeeze on profitability. Revenue sat at US$51.4m, but the company reported a net loss of US$12.4m and basic earnings per share of US$0.08 loss. For a stock that has climbed over the past three months, that gap between fragile sentiment and still heavy...

Birkenstock Holding (NYSE:BIRK) announced the resignation of board member Alexandre Arnault and is beginning a search for a new independent director. The company plans to fill the vacant seat with an independent candidate, with the stated goal of maintaining strong corporate governance. Investors and other stakeholders are watching for updates on the board search and any related governance disclosures. Consider widening your research to other footwear and consumer brands that may offer...

Curtiss-Wright just saw its stock slip about 3% on the day, even though the quarter delivered the kind of numbers many investors usually cheer. The company posted Q2 2026 revenue of US$924.0m and basic earnings per share of US$4.09, both ahead of the prior quarter, and converted those earnings into strong free cash flow according to management. The headline from this report is not a miss. It is expanding profitability in a complex aerospace and defense portfolio while the share price cools...

Genius Sports stock slipped about 3% to US$7.60 after the Q2 release, even though the headline numbers told a different story. The company crossed a psychological line by guiding full year revenue to roughly US$1.0b and flagged adjusted earnings before interest, tax, depreciation and amortisation of up to US$295m. For a sports data and betting infrastructure provider that had been defined by potential, this update pushed the conversation squarely toward cash generation and scale. The question...

Assured Guaranty stock just absorbed a sharp reality check. Shares dropped about 9% to roughly US$75, even though the company reported Q2 adjusted operating income of US$55 million, or US$1.23 per share, and highlighted record per share equity metrics. The hit came as investors weighed those solid insurance earnings against softer headline earnings per share of US$0.88 and the reminder that recent results included a large one off gain. For a stock long viewed as a capital return and book...

Central Garden & Pet stock has delivered a strong 40.0% return year to date, yet its low overall value score suggests the current share price may already reflect a lot of optimism. Year to date, Central Garden & Pet is up 40.0%, which puts extra focus on whether recent gains leave enough room for further upside. The planned majority acquisition of European pet supplies company TRIXIE can support longer term growth expectations. At the same time, the timing and execution of this expansion may...

Zoetis came into this earnings print wearing a value label, trading on an 11.6x trailing P/E that sat well below large pharma peers. The stock then dropped almost 6% in a single session, wiping away any hint of calm around the animal health story. The reason sits squarely in profit pressure. Management cut full year guidance, now pointing to an adjusted diluted earnings per share range of US$6.15 to US$6.25 and organic adjusted net income that is expected to decline mid to high single...

Nutex Health stock jumped 6.7% in the first full trading day after earnings, a sharp move for a company many investors still file mentally under small cap and controversial reimbursement story. The headline is not revenue; the story is profit. Q2 net income reached US$65.8m on revenue of US$210.8m, and trailing net profit margin now sits at 21.2% with a P/E of 6.2x. The market is quickly repricing a business that screens as inexpensive and more profitable than its reputation suggests. Like...

Atlanticus Holdings just saw its stock drop about 11% in a single session, yet the latest quarter reads more like an earnings statement from a company on the front foot than one in retreat. The credit focused lender posted Q2 2026 revenue of US$223.6m and basic earnings per share of US$3.13, both tied to net income of US$47.4m. Investors came into this print after a strong three month run in the stock, which makes the sharp pullback a reset on expectations rather than a simple verdict on the...

The market marked down MarketWise by just over 5% to US$20.25, yet the headline from Q2 is not a collapse in demand. The real story is a sharp squeeze in profitability. Revenue for the quarter sat around US$75.8m, while the company swung to a reported net loss. That pressure also shows up in the trailing net profit margin, which sits at 0.7%, well below where it was a year ago. Today’s price move looks like a fast verdict on that margin strain. It also raises a deeper question about how...

V.F (VFC) just packed several developments into two days. The company reported first quarter results, raised its fiscal 2027 revenue outlook, and named Abhishek Dalmia as Chief Financial Officer. See our latest analysis for V.F. The latest earnings report, higher fiscal 2027 revenue outlook, dividend affirmation and CFO appointment have come as V.F’s share price sits at US$14.99. Short term share price momentum is fading, with the 30 day return down 6.43% and the 90 day return down 21.02%,...

Himax Technologies just jumped 6.3% in a single session, a sharp move for a stock that had been down over the past three months. The market is latching onto one headline: earnings power snapping back in a big way. Basic earnings per share for the quarter came in at about US$0.23 on revenue of roughly US$227.4m, a clear step up from recent prints in this display chipmaker’s cycle. With the stock already trading on a rich trailing P/E of about 72x, the key question now is whether this earnings...

Manitowoc Company just shocked a skeptical market. The stock rose 32.4% to US$18.82 after traders digested a quarter that flipped from a Q1 loss to Q2 basic earnings per share of about US$0.39 and pushed net income to US$14.2m. For a crane maker often viewed as a low margin grinder, the main focus is margin repair. Adjusted EBITDA nearly doubled to US$49m with margin above 8%, helped by stronger crane demand and a meaningful tariff refund tailwind. Love the sharp margin repair at Manitowoc...

In the past week, Figma, Inc. reported second-quarter 2026 results with revenue rising to US$370.08 million from US$249.64 million a year earlier, while swinging from a US$28.23 million net profit to a US$112.15 million net loss and issuing higher full-year 2026 revenue guidance of about US$1.46 billion. The quarter marked Figma’s first full period of AI credit monetization, revealing that new AI features are expanding customer usage even as heavier AI infrastructure spending sharply...

Precision BioSciences stock barely flinched after earnings, edging only 0.9% higher to US$7.49. Yet the quarter itself was anything but quiet. The headline is a sharp swing back into loss making territory, with Q2 basic earnings per share at a loss of US$1.26 and revenue dropping to essentially zero. For a biotech that investors often value on future potential, the real story today is the strain this kind of income statement puts on the balance between patience and dilution risk. The price...

Exponent, Inc. recently reported past second-quarter 2026 results showing year-on-year growth in sales to US$148.86 million, revenue to US$171.61 million, and net income to US$29.4 million, alongside confirming a US$0.31 per-share dividend and completing a multi-year share repurchase of 13,868,342 shares. The company also raised its 2026 revenue growth guidance, signaled further quarterly net revenue growth for the second half of the year, and expanded its equity buyback authorization by...

Atlassian just delivered the kind of quarter that can reset a story. The stock came into this earnings season already strong over the past few months, then exploded another 35% to about US$149 after the release. That move reflects one thing above all else: profitability is finally showing through in a business many investors still bucket as a pure growth play. Revenue for the fourth quarter sat at about US$1.8b while basic earnings per share came in at US$0.55. A double digit GAAP...